Cargando…
Epidemiology of Hepatitis C virus infection among incarcerated populations in North Dakota
This retrospective cohort study was conducted to determine the prevalence of HCV infections among individuals incarcerated in a state prison system and identify potential contributing factors to HCV infection. North Dakota Department of Corrections and Rehabilitation (NDDOCR) data from 2009 to 2018...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963564/ https://www.ncbi.nlm.nih.gov/pubmed/35349606 http://dx.doi.org/10.1371/journal.pone.0266047 |
_version_ | 1784678015645515776 |
---|---|
author | Chandra Deb, Liton Hove, Hannah Miller, Tracy K. Pinks, Kodi Njau, Grace Hagan, John J. Jansen, Rick J. |
author_facet | Chandra Deb, Liton Hove, Hannah Miller, Tracy K. Pinks, Kodi Njau, Grace Hagan, John J. Jansen, Rick J. |
author_sort | Chandra Deb, Liton |
collection | PubMed |
description | This retrospective cohort study was conducted to determine the prevalence of HCV infections among individuals incarcerated in a state prison system and identify potential contributing factors to HCV infection. North Dakota Department of Corrections and Rehabilitation (NDDOCR) data from 2009 to 2018 was used and period prevalence was calculated for this 10-year time period. The period prevalence of HCV infection was (15.13% (95% CI 14.39–15.90) with a marginally significant (p-value: 0.0542) increasing linear trend in annual prevalence over this period. Multivariate logistic regression analysis was used to identify risk factors associated with HCV infection. The main significant independent risk factors for HCV infection in this incarcerated population were age >40 years [OR: 1.78 (1.37–2.32)]; sex [OR: 1.21 (1.03–1.43)]; race/ethnicity [OR: 1.97 (1.69–2.29)]; history of intravenous drug use (IVDU) [OR: 7.36 (6.41–8.44)]; history of needle or syringe sharing [OR: 7.57 (6.62–8.67)]; and alcohol use [OR: 0.87 (0.77–0.99)]. Study limitations include uncollected information on sexual history, frequency or duration of injection drug use and blood transfusion history of the incarcerated population. Considering the high prevalence of HCV infection and its associated risk factors, it is important to implement prevention programs such as syringe/needle exchanges and counsel with imprisoned IVD users. |
format | Online Article Text |
id | pubmed-8963564 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-89635642022-03-30 Epidemiology of Hepatitis C virus infection among incarcerated populations in North Dakota Chandra Deb, Liton Hove, Hannah Miller, Tracy K. Pinks, Kodi Njau, Grace Hagan, John J. Jansen, Rick J. PLoS One Research Article This retrospective cohort study was conducted to determine the prevalence of HCV infections among individuals incarcerated in a state prison system and identify potential contributing factors to HCV infection. North Dakota Department of Corrections and Rehabilitation (NDDOCR) data from 2009 to 2018 was used and period prevalence was calculated for this 10-year time period. The period prevalence of HCV infection was (15.13% (95% CI 14.39–15.90) with a marginally significant (p-value: 0.0542) increasing linear trend in annual prevalence over this period. Multivariate logistic regression analysis was used to identify risk factors associated with HCV infection. The main significant independent risk factors for HCV infection in this incarcerated population were age >40 years [OR: 1.78 (1.37–2.32)]; sex [OR: 1.21 (1.03–1.43)]; race/ethnicity [OR: 1.97 (1.69–2.29)]; history of intravenous drug use (IVDU) [OR: 7.36 (6.41–8.44)]; history of needle or syringe sharing [OR: 7.57 (6.62–8.67)]; and alcohol use [OR: 0.87 (0.77–0.99)]. Study limitations include uncollected information on sexual history, frequency or duration of injection drug use and blood transfusion history of the incarcerated population. Considering the high prevalence of HCV infection and its associated risk factors, it is important to implement prevention programs such as syringe/needle exchanges and counsel with imprisoned IVD users. Public Library of Science 2022-03-29 /pmc/articles/PMC8963564/ /pubmed/35349606 http://dx.doi.org/10.1371/journal.pone.0266047 Text en https://creativecommons.org/publicdomain/zero/1.0/This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication. |
spellingShingle | Research Article Chandra Deb, Liton Hove, Hannah Miller, Tracy K. Pinks, Kodi Njau, Grace Hagan, John J. Jansen, Rick J. Epidemiology of Hepatitis C virus infection among incarcerated populations in North Dakota |
title | Epidemiology of Hepatitis C virus infection among incarcerated populations in North Dakota |
title_full | Epidemiology of Hepatitis C virus infection among incarcerated populations in North Dakota |
title_fullStr | Epidemiology of Hepatitis C virus infection among incarcerated populations in North Dakota |
title_full_unstemmed | Epidemiology of Hepatitis C virus infection among incarcerated populations in North Dakota |
title_short | Epidemiology of Hepatitis C virus infection among incarcerated populations in North Dakota |
title_sort | epidemiology of hepatitis c virus infection among incarcerated populations in north dakota |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963564/ https://www.ncbi.nlm.nih.gov/pubmed/35349606 http://dx.doi.org/10.1371/journal.pone.0266047 |
work_keys_str_mv | AT chandradebliton epidemiologyofhepatitiscvirusinfectionamongincarceratedpopulationsinnorthdakota AT hovehannah epidemiologyofhepatitiscvirusinfectionamongincarceratedpopulationsinnorthdakota AT millertracyk epidemiologyofhepatitiscvirusinfectionamongincarceratedpopulationsinnorthdakota AT pinkskodi epidemiologyofhepatitiscvirusinfectionamongincarceratedpopulationsinnorthdakota AT njaugrace epidemiologyofhepatitiscvirusinfectionamongincarceratedpopulationsinnorthdakota AT haganjohnj epidemiologyofhepatitiscvirusinfectionamongincarceratedpopulationsinnorthdakota AT jansenrickj epidemiologyofhepatitiscvirusinfectionamongincarceratedpopulationsinnorthdakota |